Gazouli M - Search Results

1

MicroRNAs and drug resistance in colorectal cancer with special focus on 5-fluorouracil.

Pouya FD, Gazouli M, Rasmi Y, Lampropoulou DI, Nemati M. Pouya FD, et al. Among authors: gazouli m. Mol Biol Rep. 2022 Jun;49(6):5165-5178. doi: 10.1007/s11033-022-07227-1. Epub 2022 Feb 25. Mol Biol Rep. 2022. PMID: 35212928 Review.

2

The role of microRNAs in liver cancer.

Papaconstantinou I, Karakatsanis A, Gazouli M, Polymeneas G, Voros D. Papaconstantinou I, et al. Among authors: gazouli m. Eur J Gastroenterol Hepatol. 2012 Mar;24(3):223-8. doi: 10.1097/MEG.0b013e3283505063. Eur J Gastroenterol Hepatol. 2012. PMID: 22228372 Review.

3

Transcription factor ATF-3 regulates allele variation phenotypes of the human SLC11A1 gene.

Taka S, Gazouli M, Politis PK, Pappa KI, Anagnou NP. Taka S, et al. Among authors: gazouli m. Mol Biol Rep. 2013 Mar;40(3):2263-71. doi: 10.1007/s11033-012-2289-1. Epub 2012 Nov 27. Mol Biol Rep. 2013. PMID: 23187734

4

Association of the miR-146aC>G, miR-149T>C, and miR-196a2T>C polymorphisms with gastric cancer risk and survival in the Greek population.

Dikeakos P, Theodoropoulos G, Rizos S, Tzanakis N, Zografos G, Gazouli M. Dikeakos P, et al. Among authors: gazouli m. Mol Biol Rep. 2014 Feb;41(2):1075-80. doi: 10.1007/s11033-013-2953-0. Epub 2013 Dec 31. Mol Biol Rep. 2014. PMID: 24379078

5

Association of CD133 polymorphisms and response to bevacizumab in patients with metastatic colorectal cancer.

Aravantinos G, Isaakidou A, Karantanos T, Sioziou A, Theodoropoulos GE, Pektasides D, Gazouli M. Aravantinos G, et al. Among authors: gazouli m. Cancer Biomark. 2015;15(6):843-50. doi: 10.3233/CBM-150528. Cancer Biomark. 2015. PMID: 26406410

6

Long non-coding RNA polymorphisms and prediction of response to chemotherapy based on irinotecan in patients with metastatic colorectal cancer.

Lampropoulou DI, Aravantinos G, Katifelis H, Lazaris F, Laschos K, Theodosopoulos T, Papadimitriou C, Gazouli M. Lampropoulou DI, et al. Among authors: gazouli m. Cancer Biomark. 2019;25(2):213-221. doi: 10.3233/CBM-182383. Cancer Biomark. 2019. PMID: 31045514

7

MiR-218 and miR-100 polymorphisms as markers of irinotecan-based chemotherapy response in metastatic colorectal cancer.

Lampropoulou DI, Aravantinos G, Laschos K, Theodosopoulos T, Papadimitriou C, Gazouli M. Lampropoulou DI, et al. Among authors: gazouli m. Int J Colorectal Dis. 2019 Nov;34(11):1871-1877. doi: 10.1007/s00384-019-03401-3. Epub 2019 Oct 9. Int J Colorectal Dis. 2019. PMID: 31598748

8

Exosomal noncoding RNAs in cholangiocarcinoma: Laboratory noise or hope?

Laschos K, Lampropoulou DI, Aravantinos G, Piperis M, Filippou D, Theodoropoulos G, Gazouli M. Laschos K, et al. Among authors: gazouli m. World J Gastrointest Surg. 2020 Oct 27;12(10):407-424. doi: 10.4240/wjgs.v12.i10.407. World J Gastrointest Surg. 2020. PMID: 33194090 Free PMC article. Review.

9

Association between homeobox protein transcript antisense intergenic ribonucleic acid genetic polymorphisms and cholangiocarcinoma.

Lampropoulou DI, Laschos K, Aravantinos G, Georgiou K, Papiris K, Theodoropoulos G, Gazouli M, Filippou D. Lampropoulou DI, et al. Among authors: gazouli m. World J Clin Cases. 2021 Mar 16;9(8):1785-1792. doi: 10.12998/wjcc.v9.i8.1785. World J Clin Cases. 2021. PMID: 33748227 Free PMC article.

10

MicroRNAs as therapeutic targets in breast cancer metastasis.

Pouya FD, Rasmi Y, Gazouli M, Zografos E, Nemati M. Pouya FD, et al. Among authors: gazouli m. Drug Deliv Transl Res. 2022 May;12(5):1029-1046. doi: 10.1007/s13346-021-00999-2. Epub 2021 May 13. Drug Deliv Transl Res. 2022. PMID: 33987801 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

376 results

Search Page